Tag Archives: alzheimers

BIO Technology Transfer Symposium: Funding that First $2 Million

2-mill

With creative funding schemes picking up steam and nontraditional funders taking an interest in biotech, what can universities and start-ups expect in their right first-round financing structure? At the BIO Technology Transfer Symposium, a panel examined various funding sources as well as the factors that influence investment decisions and the ins and outs of early stage financing deals. William Tucker, executive director, Innovation Alliances and Services, University of California Office of the President, moderated a Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

“Alz” Well That Ends Well: The Beta-Amyloid Debate in Alzheimer’s Research

alzheimers

Researchers and clinicians alike believe there is substantial evidence to support the hypothesis that Alzheimer’s disease (AD) may be caused by deposition of amyloid beta-peptide (Abeta) in plaques in brain tissue. But drugs targeted towards the beta-amyloid have met with significant setbacks challenging whether the target is, in fact, real. With several late stage drugs targeting beta-amyloid poised for market entry, a panel of opinion leaders in the treatment of Alzheimer’s and scientific industry specialists Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

“The Ultimate Pig”

The 7th Transgenic Animal Conference held this week in Tahoe, Calif. came to a close today. But not before the “buzz” was felt about the advances in the area of genetic engineering (GE) of pigs for advancing human health. Researchers from Denmark, Germany, Ireland, and the United States astounded the over 100 scientists in the audience with their findings on GE pigs. GE pigs are successfully being studied that will serve as animal models for Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,